Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Garazha

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancers|October 3, 2018
Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression DataMaxim Sorokin, Roman Kholodenko, Maria Suntsova, et al.
Cold Spring Harbor Molecular Case Studies|February 16, 2020
RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancerMaxim Sorokin, Elena Poddubskaya, Madina Baranova, et al.
Cells|August 26, 2023
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR PathwaysDmitri Kamashev, Nina Shaban, Timofey Lebedev, et al.
F&S Science|August 11, 2021
COVID-19-associated inhibition of energy accumulation pathways in human semen samplesLeila Adamyan, Vladimir Elagin, Valeriy Vechorko, et al.
Proteomes|September 27, 2023
Algorithmically Reconstructed Molecular Pathways as the New Generation of Prognostic Molecular Biomarkers in Human Solid CancersMarianna Zolotovskaia, Maks Kovalenko, Polina Pugacheva, et al.
Aging|November 22, 2016
Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cellsIvan Petrov, Maria Suntsova, Olga Mutorova, et al.
Seminars in Cancer Biology|June 24, 2018
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Frontiers in Immunology|December 26, 2024
Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patientsElena Poddubskaya, Maria Suntsova, Marina Lyadova, et al.
BMC Cancer|November 1, 2022
Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing dataMaxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, et al.
Scientific Data|April 25, 2019
Atlas of RNA sequencing profiles for normal human tissuesMaria Suntsova, Nurshat Gaifullin, Daria Allina, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancers|October 3, 2018
Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression DataMaxim Sorokin, Roman Kholodenko, Maria Suntsova, et al.
Cold Spring Harbor Molecular Case Studies|February 16, 2020
RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancerMaxim Sorokin, Elena Poddubskaya, Madina Baranova, et al.
Cells|August 26, 2023
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR PathwaysDmitri Kamashev, Nina Shaban, Timofey Lebedev, et al.
F&S Science|August 11, 2021
COVID-19-associated inhibition of energy accumulation pathways in human semen samplesLeila Adamyan, Vladimir Elagin, Valeriy Vechorko, et al.
Proteomes|September 27, 2023
Algorithmically Reconstructed Molecular Pathways as the New Generation of Prognostic Molecular Biomarkers in Human Solid CancersMarianna Zolotovskaia, Maks Kovalenko, Polina Pugacheva, et al.
Aging|November 22, 2016
Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cellsIvan Petrov, Maria Suntsova, Olga Mutorova, et al.
Seminars in Cancer Biology|June 24, 2018
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Frontiers in Immunology|December 26, 2024
Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patientsElena Poddubskaya, Maria Suntsova, Marina Lyadova, et al.
BMC Cancer|November 1, 2022
Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing dataMaxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, et al.
Scientific Data|April 25, 2019
Atlas of RNA sequencing profiles for normal human tissuesMaria Suntsova, Nurshat Gaifullin, Daria Allina, et al.
Pageof 5